Armistice Capital, LLC 13D and 13G filings for Aridis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 9:38 pm Unchanged | 2025-06-30 | 13G | Aridis Pharmaceuticals, Inc. ARDS | Armistice Capital, LLC | 5,096,251 11.430% | 0 (Unchanged) | Filing |
| 2025-08-14 9:34 pm Purchase | 2025-06-30 | 13G | Aridis Pharmaceuticals, Inc. ARDS | Armistice Capital, LLC | 703,557 6.630% | 703,557 (New Position) | Filing |
| 2025-05-15 3:22 pm Unchanged | 2025-03-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS | Armistice Capital, LLC | 5,096,251 11.430% | 0 (Unchanged) | Filing |
| 2025-02-14 4:49 pm Unchanged | 2024-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS | Armistice Capital, LLC | 5,096,251 11.430% | 0 (Unchanged) | Filing |
| 2024-11-14 4:46 pm Purchase | 2024-09-30 | 13G | Aridis Pharmaceuticals, Inc. ARDS | Armistice Capital, LLC | 5,096,251 10.820% | 470,061 (+10.16%) | Filing |
| 2024-02-14 2:21 pm Purchase | 2023-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS | Armistice Capital, LLC | 4,626,190 9.990% | 1,629,079 (+54.35%) | Filing |
| 2023-02-14 12:00 pm Purchase | 2022-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS | Armistice Capital, LLC | 2,997,111 9.990% | 2,997,111 (New Position) | Filing |
| 2023-02-14 11:59 am Purchase | 2022-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS | Armistice Capital, LLC | 2,997,111 9.990% | 2,997,111 (New Position) | Filing |